会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 52. 发明授权
    • Engineered immunoglobulin FC polypeptides
    • 工程化的免疫球蛋白FC多肽
    • US08952132B2
    • 2015-02-10
    • US13367063
    • 2012-02-06
    • George GeorgiouSang Taek JungWilliam KeltonTae Hyun Kang
    • George GeorgiouSang Taek JungWilliam KeltonTae Hyun Kang
    • C07K17/00C07K16/00C07K1/00C07K16/28C12P21/08
    • C07K16/283C07K16/32C07K2317/14C07K2317/41C07K2317/52C07K2317/72C07K2317/732C07K2317/92C07K2319/30
    • Methods and compositions involving polypeptides having an aglycosylated antibody Fc domain. In certain embodiments, polypeptides have an aglycosylated Fc domain that contains one or more substitutions compared to a native Fc domain. Additionally, some embodiments involve an Fc domain that is binds some Fc receptors but not others. For example, polypeptides are provided with an aglycosylated Fc domain that selectively binds FcγRIIa, but that is significantly reduced for binding to the highly homologous FcγRIIb receptors. Furthermore, methods and compositions are provided for promoting antibody-dependent cell-mediated toxicity (ADCC) using a polypeptide having a modified aglycosylated Fc domain and a second non-Fc binding domain, which can be an antigen binding region of an antibody or a non-antigen binding region. Some embodiments concern antibodies with such polypeptides, which may have the same or different non-Fc binding domain.
    • 涉及具有糖基化抗体Fc结构域的多肽的方法和组合物。 在某些实施方案中,多肽具有与天然Fc结构域相比含有一个或多个取代的糖基化Fc结构域。 另外,一些实施方案涉及结合一些Fc受体而不是其它Fc受体的Fc结构域。 例如,提供了多肽选择性结合FcγRIIa的糖基化Fc结构域,但是与结合高度同源的FcγRIIb受体相比显着降低。 此外,提供了使用具有修饰的糖基化Fc结构域和第二非Fc结合结构域的多肽来促进抗体依赖性细胞介导的毒性(ADCC)的方法和组合物,其可以是抗体或非抗体的抗原结合区域 - 抗原结合区。 一些实施方案涉及具有这样的多肽的抗体,其可以具有相同或不同的非Fc结合结构域。
    • 57. 发明授权
    • Engineering of leader peptides for the secretion of recombinant proteins in bacteria
    • 用于在细菌中分泌重组蛋白的前导肽的工程
    • US07419783B2
    • 2008-09-02
    • US10289135
    • 2002-11-05
    • George GeorgiouMatthew DeLisa
    • George GeorgiouMatthew DeLisa
    • C12Q1/68C12P21/00C07H21/04C07K14/00C07K14/195
    • C12N15/1051C07K2319/034C07K2319/60C07K2319/61C07K2319/95C12N15/1086C12N15/625
    • The present invention provides methods of isolating of leader peptides capable of directing export of heterologous proteins from the bacterial cytoplasm. The methods rely on the screening of libraries of putative leader peptides or of leader peptide mutants for sequences that allow rapid export and thus can rescue a short-lived reporter protein from degradation in the cytoplasm. The mutant leader peptides identified herein are shown to confer significantly higher steady state levels of export not only for short-lived reporter protein but also for other stable, long-lived proteins. These leader peptides can be used to direct or enhance protein secretion. The present invention further discloses methods for the export of cytoplasmically folded protein via the Tat pathway. Proteins having disulfide bonds are first folded within the cytoplasm in suitable oxidizing mutant strains. Such cytoplasmically pre-folded proteins containing disulfide bonds are then exported via the Tat pathway.
    • 本发明提供了能够引导异源蛋白从细菌细胞质导出的前导肽的分离方法。 这些方法依赖于筛选出推定的前导肽或前导肽突变体的文库,用于允许快速出口的序列,从而可以拯救短命的报道蛋白免于细胞质中的降解。 本文鉴定的突变体前导肽显示出不仅对于短寿命报道蛋白而且对于其他稳定的长寿命蛋白质也具有显着更高的稳态出口水平。 这些前导肽可用于引导或增强蛋白质分泌。 本发明还公开了通过Tat途径输出细胞质折叠的蛋白质的方法。 具有二硫键的蛋白质首先在合适的氧化突变株中在细胞质内折叠。 然后通过Tat途径输出含有二硫键的这种细胞质上预折叠的蛋白质。
    • 59. 发明申请
    • COMBINATORIAL PROTEIN LIBRARY SCREENING BY PERIPLASMIC EXPRESSION
    • 通过周边表达组合蛋白图书馆筛选
    • US20070099267A1
    • 2007-05-03
    • US11466352
    • 2006-08-22
    • Barrett HarveyGeorge GeorgiouBrent Iverson
    • Barrett HarveyGeorge GeorgiouBrent Iverson
    • C12P21/06C07H21/04C12N15/74C07K14/245
    • C12N15/1034C07K2319/034C12N15/1037C12N15/1086C40B40/02
    • The invention overcomes the deficiencies of the prior art by providing a rapid approach for isolating binding proteins capable of binding small molecules and peptides. In the technique, libraries of candidate binding proteins, such as antibody sequences, are expressed in the periplasm of gram negative bacteria and mixed with a labeled ligand. In clones expressing recombinant polypeptides with affinity for the ligand, the concentration of the labeled ligand bound to the binding protein is increased and allows the cells to be isolated from the rest of the library. Where fluorescent labeling of the target ligand is used, cells may be isolated by fluorescence activated cell sorting (FACS). The approach is more rapid than prior art methods and avoids problems associated with the outer surface-expression of ligand fusion proteins employed with phage display.
    • 本发明通过提供用于分离能够结合小分子和肽的结合蛋白的快速方法来克服现有技术的缺陷。 在该技术中,候选结合蛋白(例如抗体序列)的文库在革兰氏阴性细菌的周质中表达并与标记的配体混合。 在表达对配体具有亲和性的重组多肽的克隆中,与结合蛋白结合的标记配体的浓度增加,并允许细胞与文库的其余部分分离。 当使用靶配体的荧光标记时,可以通过荧光激活细胞分选(FACS)分离细胞。 该方法比现有技术方法更快速,并且避免了与噬菌体展示一起使用的配体融合蛋白的外表面表达相关的问题。